{"name":"Cosmo Technologies Ltd","slug":"cosmo-technologies-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CB-03-10","genericName":"CB-03-10","slug":"cb-03-10","indication":"Other","status":"phase_1"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Methylene Blue MMX®","genericName":"Methylene Blue MMX®","slug":"methylene-blue-mmx","indication":"Mild cognitive impairment","status":"phase_3"}]}],"pipeline":[{"name":"CB-03-10","genericName":"CB-03-10","slug":"cb-03-10","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Methylene Blue MMX®","genericName":"Methylene Blue MMX®","slug":"methylene-blue-mmx","phase":"phase_3","mechanism":"Methylene Blue MMX is a modified-release formulation of methylene blue that acts as a mitochondrial function enhancer and antioxidant to improve cognitive and neurological outcomes.","indications":["Mild cognitive impairment","Alzheimer's disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNTXBkMXZSS2ZjN1lvQ3lqaTRHbV9MVExGcGNtc3p2SEdXbi1FSkwtUm1xMnljUi03NExSandaNTFERkNFcHVwVTh0YVp2S05mNVFHNXV6d1pVTGd0LW1vUjZFcHdabEd5UXpGcFU2dnBJb3FOR2RhZ3NDcVBPNGlHNE9JVFFUOEs3UDRvUQ?oc=5","date":"2026-03-13","type":"pipeline","source":"Yahoo Finance","summary":"Is It Too Late To Consider Cosmo Pharmaceuticals (SWX:COPN) After A 75% One Year Surge? - Yahoo Finance","headline":"Is It Too Late To Consider Cosmo Pharmaceuticals (SWX:COPN) After A 75% One Year Surge?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-13","type":"pipeline","source":"simplywall.st","summary":"Is It Time To Reassess Cosmo Pharmaceuticals (SWX:COPN) After The Recent Share Price Pullback - simplywall.st","headline":"Is It Time To Reassess Cosmo Pharmaceuticals (SWX:COPN) After The Recent Share Price Pullback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNdC1wUXA4M2d0OHc5eENPYWVwRzEtZWFGUDVaMDVFZi16VlNkbmNrbVlzQkszd0cxU3l3dVdxUkozdUFMOGRYTVRFTUY1dTB6MV81VzBJdzRON0kxaHBnQTNjS1JWNWZxa1JoaFFZR1VLZ1FFT1JSdy1YdW9fR19zWVZ5YnJfZFd4SXAyS1NRZkRzcWpBb0k1M0V1NUFWZzJVdXdXemEwQW8wR3d4aU1tNHpNczZmZXd5QXFz?oc=5","date":"2026-03-05","type":"pipeline","source":"Stock Titan","summary":"New AI aims to catch early neoplasia in Barrett's esophagus - Stock Titan","headline":"New AI aims to catch early neoplasia in Barrett's esophagus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQN0JJTWk0SXlsSElBQzRQak5rTU9xWTRXTm0tcDdGWU1kUVZjWHFlQ0JsTnFldlkyWTE5eVp0Y3RaaGlNUDJQdlJoMzJQa0ZsWGZZR3JlTTZqNXlwMzV1ODFtcldnWkljNi14eGltLWNMY3FNZmJNSDh5ckZZUjJnRFRkcDJsalo1MFN4SHBZVQ?oc=5","date":"2026-02-24","type":"pipeline","source":"Yahoo Finance","summary":"Assessing Cosmo Pharmaceuticals (SWX:COPN) Valuation After Strong Multi Year Returns And Recent Share Price Pullback - Yahoo Finance","headline":"Assessing Cosmo Pharmaceuticals (SWX:COPN) Valuation After Strong Multi Year Returns And Recent Share Price Pullback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQY1hnbDB6OUtaOThSZEF5SktjS2UtN24tMzUwMElzYk5WRUJldzRkTVpuQjE1V080QWRLWTlxZEU1NGxhZjcwTVRxaklvdmVzcEdEWFpGSWdDRTVwbWY1YVB0eXhNU2IwdUtxNThVSTNqY2EwRS1qbXFWSzZuVU1kTmo0ODZpMWpjRnc5MlBobDNwQ3V4X2xNaWhtUTEtNXdFY0t1X1RlQ0dyX2lEa1pER3JSTTBTQWMxbUVCR1llNA?oc=5","date":"2026-02-11","type":"pipeline","source":"Quiver Quantitative","summary":"Cosmos Health Inc. Expands Digital Assets Program with $500,000 Investment in Bitcoin | COSM Stock News - Quiver Quantitative","headline":"Cosmos Health Inc. Expands Digital Assets Program with $500,000 Investment in Bitcoin | COSM Stock News","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-04","type":"pipeline","source":"simplywall.st","summary":"Cosmo Pharmaceuticals (SWX:COPN): Does the New Institutional Stake Redefine Its Capital Allocation Playbook? - simplywall.st","headline":"Cosmo Pharmaceuticals (SWX:COPN): Does the New Institutional Stake Redefine Its Capital Allocation Playbook?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVlZ6UHBXb0xLLVZUZE9CYkRwbjRmOVo4YWxiT3hGYUJiV0thbnZXbDVZVTF5TzJ0OGZGOWp0VDVmcjJLVEZFV01yV2kxc0hfUU9vY1V6UEhUZmtwWHlFdFJZbERVQ0RmMl9WaWtBTUdOSzFCc0xtd0EwUW9yT0Jsek9Lb1haWTdqY05VVkhPaTRDZnZ0VjMwT1NsWEFIVE05emZJaF9pNWFrdXVxZ2p2Z0Fn?oc=5","date":"2026-02-03","type":"pipeline","source":"TMX Newsfile","summary":"Cosmo Pharmaceuticals Announces Private Placement of Treasury Shares - TMX Newsfile","headline":"Cosmo Pharmaceuticals Announces Private Placement of Treasury Shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQUXFBcXU3UVZkRWhrUWpIRzNFTFpMenRoNVZBWERZTFNNbXU3Y21JVzYwT0hqQmNzMDNZTzg2X1lZc0NiWkticFJkQWR3Q1VYTW9BNTdLbFdOeXktYlBydG1Xa1V5Rkptc0hsOElYN194RE85OVhqOUwyNkV5MDYwSUYwbUFSUmUyZ2lnWGFVSG95b3NEQmY4ZTZPRHpzaUtobnZhc3M4dlVVUWNrRnBINmFaYlNZX3JyNVRLaExrdXNObHFiNlp6MjN6cw?oc=5","date":"2026-01-14","type":"pipeline","source":"Quiver Quantitative","summary":"Zacks Small-Cap Research Initiates Coverage on Cosmos Health Inc. with $4.50 Valuation Per Share - Quiver Quantitative","headline":"Zacks Small-Cap Research Initiates Coverage on Cosmos Health Inc. with $4.50 Valuation Per Share","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNZEtYWWd6ZFNGUVE4MnBCQnRocWxFcGZJTnU3X3dZT2E3LVlVRnhqVmhpTlZkUHFwWVFPZmMtQndZMVlQYmo3NjR1ellkeFZKRG5SVHFWMlZpS29ZbjI3bmxtOEktVmVZV1Ytd2RFOFhpOFIxdjB1N196eXdfMnZjS3hZejExLTMzVkNCb2d6ZEJtMWV2THNSb2hWcW41SlFBeG9CQkxnV255cFlETmFUSjI1RldNeUsxOU1lNERYQVRieGZlTzRDeDhVM1QxUDRydzFaWVF6cWJtUQ?oc=5","date":"2025-12-08","type":"trial","source":"Global Cosmetics News","summary":"Cosmo Pharmaceuticals Shares Surge After Male Hair Loss Treatment Delivers Breakthrough Phase III Results - Global Cosmetics News","headline":"Cosmo Pharmaceuticals Shares Surge After Male Hair Loss Treatment Delivers Breakthrough Phase III Results","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOODAwRmpwYXZydkRpdzBXUXNEYWZ0eVpWc2dFMnUzZjF2MDB1dlpOX19fa2MwT3JzVTdWMTlaR0F1empBZ0x0Q28xVUZiMmpWVDZYM0wzUzhkTXVmQlRvMnhOdUJRSVc5TEtqV3ZyN1huZTgyVlZIZFotRVU1RG0xRk9lc05UelhxOVdpX1RJNTlfZG1ZNmxQbEljbGI2UGNCQmZGS1pqMVRXcGxqYzJvOGdlbjBUcGQ1STA5c3gtNXFFNE1BcjJxX3lBNkZ6ZFo0bnRSaVNxMThrdGhtckIzU3pHcVNFSUhDUlJFbUIzdW5BLVJTWjZpMDlzYVpjN1U5TkVuNG1YNDczeDY2eFdkQkFCZHBhRUJZ?oc=5","date":"2025-12-01","type":"pipeline","source":"PR Newswire","summary":"Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe - PR Newswire","headline":"Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 co","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-18","type":"pipeline","source":"ET Manufacturing","summary":"Glenmark, Cosmo Pharmaceuticals get marketing authorisation for Winlevi in Europe - ET Manufacturing","headline":"Glenmark, Cosmo Pharmaceuticals get marketing authorisation for Winlevi in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQSE9McmVSalJibWtTeF9PUXhtMUxCdFUxM2tnYjVKQ3RYMXZ0eW9oRDlRS1NNZXMtTXZxanZPWE0wd3M0R3JVa19yVXdtQTdHSGxrTzNEUVpyNDFUckNuYlJ4QlNWaVZvSGc1emNTMEdrWFdtVGwxTFpDVXBHUGZrV0h2LXhKLWhEQ1ZENC1IYw?oc=5","date":"2025-11-14","type":"pipeline","source":"Yahoo Finance","summary":"Cosmo Pharmaceuticals (SWX:COPN): Assessing Valuation Following Recent Share Price Momentum - Yahoo Finance","headline":"Cosmo Pharmaceuticals (SWX:COPN): Assessing Valuation Following Recent Share Price Momentum","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}